1,004
Views
12
CrossRef citations to date
0
Altmetric
Letters to the Editor

Papillary serous carcinomas of the uterine cervix and paraneoplastic cerebellar degeneration: A report of two cases

, , , , , & show all
Pages 1590-1593 | Received 30 Sep 2007, Published online: 08 Jul 2009

Figures & data

Figure 1.  A – low power view of normal cervix on the left and endocervical adenocarcinoma on the right. B – papillary serous adenocarcinoma of uterine cervix with psamomma body formation.

Figure 1.  A – low power view of normal cervix on the left and endocervical adenocarcinoma on the right. B – papillary serous adenocarcinoma of uterine cervix with psamomma body formation.

Figure 2.  A – saggital T2-weighted pelvic MRI showing a mass in the lower third of the uterus relatively hyperintense to myometrium. B – saggital oblique T2-weighted sequence demonstrating a relatively hyperintense left adnexal mass medial to the left ovary.

Figure 2.  A – saggital T2-weighted pelvic MRI showing a mass in the lower third of the uterus relatively hyperintense to myometrium. B – saggital oblique T2-weighted sequence demonstrating a relatively hyperintense left adnexal mass medial to the left ovary.

Figure 3.  T2-weighted axial MRI-brain. CSF lies within the folia of the cerebellum secondary to parenchymal cerebellar loss.

Figure 3.  T2-weighted axial MRI-brain. CSF lies within the folia of the cerebellum secondary to parenchymal cerebellar loss.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.